EXAMINE THIS REPORT ON MBL77

Not all sufferers with CLL require therapy. Regardless of all modern developments, the iwCLL however endorses watchful observation for sufferers with asymptomatic disease.86 This advice is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each